Comprehensive Review of Incretins: From Semaglutide to Orforglipron and Retatrutide
Psychiatric Times provides educational review of the incretin system covering the shift toward oral nonpeptide small-molecule GLP-1 RAs and triple agonists expected within 1-2 years.